Antag Therapeutics

Copenhagen, Capital Region, Denmark

+45 21 45 65 37 ★

http://www.antagtherapeutics.com/

Company profile

Antag Therapeutics company profile

Antag Therapeutics is a biotechnology company developing metabolic and anti-obesity therapeutic drugs. It offers the development of peptide-based GIP receptor antagonists in order to monitor dietary-related metabolic diseases through the infusion to decrease blood flow and lipid uptake in adipose tissue.

Business identity

Website: http://www.antagtherapeutics.com/
Contact email: [email protected]
Phone number: +45 21 45 65 37
Operating status: Active
Company type: For Profit
Employee range: 00001-00010 employees
Revenue range: $50K+
Founded: 2017-01-01

Headquarters

Headquarters: Copenhagen, Capital Region, Denmark
Postal code: 2200
Country code: DK
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 3
Total equity funding: $90.8M
Last funding: Series A / $84.1M / 2024-12-04
Last equity funding: Series A / $84.1M
Investors: 10
Lead investors: 2
Founders: 4
Articles: 30

Categories and groups

Biotechnology Life Science Medical Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Alexander Sparre- UlrichAndreas LaustsenJens Juul HolstMette Marie Rosenkilde

Lead investors

Novo HoldingsVersant Ventures

Investors

Export and Investment FundNovo HoldingsSR OneVaekstfondenVersant Ventures

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.